I. Izquierdo

E. Arnáiz, F. Horak, R. Zieglmayer, 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

A 12‐week placebo‐controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis

I. Agache, J. Maspero, I. Izquierdo, 2008, Allergy.

Cardiac Safety of Rupatadine in a Single‐Ascending‐Dose and Multiple‐Ascending‐Dose Study in Healthy Japanese Subjects, Using Intensive Electrocardiogram Assessments—Comparison With the Previous White Caucasian Thorough QT Study

G. Ferber, J. Täubel, S. Fernandes, 2018, Clinical pharmacology in drug development.

Rupatadine does not potentiate the CNS depressant effects of lorazepam: randomized, double-blind, crossover, repeated dose, placebo-controlled study.

R. Antonijoan, M. Ballester, M. Barbanoj, 2010, British journal of clinical pharmacology.

New transcriptome and clinical findings of platelet‐activating factor in chronic spontaneous urticaria: Pathogenic and treatment relevance

A. Giménez-Arnau, L. Nonell, R. Gimeno, 2022, BioFactors.

Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria.

A. Giménez-Arnau, M. Ferran, M. Maurer, 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Rupatadine in the treatment of chronic idiopathic urticaria: a double‐blind, randomized, placebo‐controlled multicentre study

E. Arnáiz, A. Giménez-Arnau, S. Ianoși, 2007, Allergy.

Safety of Rupatadine Administered Over a Period of 1 Year in the Treatment of Persistent Allergic Rhinitis

I. Antépara, I. Izquierdo, A. Cuvillo, 2009, Drug safety.

Reduction of nasal volume after allergen-induced rhinitis in patients treated with rupatadine: a randomized, cross-over, double-blind, placebo-controlled study.

J. Mullol, J. Bartra, C. Picado, 2009, Journal of investigational allergology & clinical immunology.

Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial

F. Marmouz, I. Izquierdo, J. Giralt, 2011, Journal of asthma and allergy.

The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo‐ controlled treatment with rupatadine 10 and 20 mg

M. Maurer, I. Izquierdo, A. Giménez-Arnau, 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study.

L. Dubertret, E. Arnáiz, I. Izquierdo, 2007, European journal of dermatology : EJD.

Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2–11 years

L. Barkai, M. Maurer, P. Potter, 2016, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Rupatadine 20 mg and 40 mg are Effective in Reducing the Symptoms of Chronic Cold Urticaria.

A. Giménez-Arnau, M. Maurer, M. Church, 2016, Acta dermato-venereologica.

PD39 - Application of population pharmacokinetic modeling and simulation in the design of the optimal dose regime of rupatadine in children 2-5 year old children

M. Valle, E. Santamaría, I. Izquierdo, 2014, Clinical and Translational Allergy.

Rupatadine oral solution in children with persistent allergic rhinitis: A randomized, double‐blind, placebo‐controlled study

L. Barkai, René A Baillieau, P. Potter, 2013, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.

R. Antonijoan, M. Barbanoj, M. Merlos, 2008, Clinical therapeutics.

Efficacy of flutrimazole 1% powder in the treatment of tinea pedis

I. Izquierdo, E. Boncompte, M. Alguero, 2003, Mycoses.

A double‐blind, randomized comparative trial: flutrimazole 1% solution versus bifonazole 1% solution once daily in dermatomycoses

S. Videla, A. R. Noriega, I. Izquierdo, 1995, Mycoses.

Flutrimazole 1% dermal cream in the treatment of dermatomycoses: a multicentre, double-blind, randomized, comparative clinical trial with bifonazole 1% cream. Efficacy of flutrimazole 1% dermal cream in dermatomycoses. Catalan Flutrimazole Study Group.

S. Videla, I. Gich, J. Forn, 1995, Dermatology.

Flutrimazole 1% dermal cream in the treatment of dermatomycoses: a randomized, multicentre, double‐blind, comparative clinical trial with 1% clotrimazole cream

S. Videla, J. Forn, I. Izquierdo, 1994, Mycoses.

[Review of the clinical efficacy of flutrimazole gel in the treatment of dandruff and/or seborrheic dermatitis.].

I. Izquierdo, E. Boncompte, M. Alguero, 1998, Revista iberoamericana de micologia.